MCL1 and acute myeloid leukemia: MCL-1 inhibitor S63845 also reduced GPX gene expression in KG1A cells after 24 h treatment, though, in general, 72-h-long treatments with metformin, S63845 and their combinations, tended to upregulate GPX expression in tested AML cells.